An International Publisher for Academic and Scientific Journals
Author Login 
SAS Journal of Medicine | Volume-9 | Issue-01
Psoriasis and COVID 19: Exacerbation Following Hydroxychloroquine: A Case Report
Naji Chadia, Oujenane Khadija, Aboudourib Maryem, Hocar Ouafa, Amal Said
Published: Jan. 11, 2023 | 141 96
DOI: 10.36347/sasjm.2023.v09i01.006
Pages: 27-29
Downloads
Abstract
Psoriasis is a chronic and multisystemic inflammatory disease, several factors can trigger it or aggravate it, including certain drugs including hydroxychloroquine. This drug, widely prescribed for COVID 19 infection, can trigger a flare-up of psoriasis, particularly the pustular form. Furthermore, patients with coronavirus 2019 infection, have increased plasma concentrations of inflammation-related cytokines which are also implicated in the etiopathogenesis of psoriasis, this may suggest that COVID-19 may be a new entity which exacerbates psoriasis. We report the observation of a patient who presented with psoriasis exacerbated by taking hydroxychloroquine following infection with covid 19.